AI assistant
STADA Arzneimittel AG — M&A Activity 2012
Jan 1, 2012
412_rns_2012-01-01_3b8428c8-ff86-4447-a499-41e05dbbe85c.html
M&A Activity
Open in viewerOpens in your device viewer
News Details
Ad-hoc | 1 January 2012 13:39
STADA: Withdrawal from purchase of the Grünenthal branded product portfolio in Central Europe
STADA Arzneimittel AG / Key word(s): Mergers & Acquisitions
01.01.2012 13:39
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
Bad Vilbel, January 1, 2012 - Today, on January 1, 2012, STADA Arzneimittel
AG exercised its contractual right to withdraw from the purchase of a
branded product portfolio from Grünenthal for EU markets in Central Europe
(including Poland, etc.), after the responsible anti-trust authorities had
not approved the agreed transaction prior to the expiry of the
contractually agreed so-called 'long stop date' (as of December 31, 2011)
(see ad hoc release of May 12, 2011 on the exclusive contract negotiations,
published via DGAP, and ad hoc update of July 22, 2011 on the signing of
the contracts, published via DGAP, as well as ad hoc update of December 30,
2011 on the conclusion of the purchase in Eastern Europe and the Middle
East, published via DGAP). The purchase price for the branded product
portfolio including the sales structures for Eastern Europe and the Middle
East is thus reduced from approx. EUR 360 million to approx. EUR 152
million.
Additional information:
STADA Arzneimittel AG / Corporate Communications / Stadastraße 2-18 / D -
61118 Bad Vilbel /
Phone: +49 (0) 6101 603-113 / Fax: +49 (0) 6101 603-506 / E-mail:
[email protected]
Or visit us in the Internet at www.stada.com.
01.01.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: [email protected]
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard);
Freiverkehr in Berlin, Hamburg, Hannover, München, Stuttgart
End of Announcement DGAP News-Service